149 件 ・ 関連度順
概要と使いどころ
This skill should be used when the user asks to "analyze experimental results", "run strict statistical analysis", "compare model performance", "generate scientific figures", "check significance", "do ablation analysis", or mentions interpreting experiment data with rigorous statistics and visualization. It focuses on strict analysis bundles, not Results-section prose.
日本語の概要は準備中です。原文の説明を表示しています。
Parallel control variable combination search via Stata. Exhaustively searches all subsets of optional controls to find the combination that maximises |t| of the independent variable. Activates when user says: "控制变量搜索", "搜控制变量", "control variable search", "跑控制变量组合", "暴力搜索", "调控制变量".
日本語の概要は準備中です。原文の説明を表示しています。
Write competitive research proposals for NSF, NIH, DOE, and DARPA. Agency-specific formatting, review criteria, budget preparation, broader impacts, significance statements, innovation narratives, and compliance with submission requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Apply the ScholarEval framework to systematically evaluate scholarly work across quality dimensions (novelty, rigor, significance, and clarity). Use to critique academic papers, research proposals, literature reviews, or grant applications and produce a structured, criterion-based assessment.
日本語の概要は準備中です。原文の説明を表示しています。
Write competitive research proposals for NSF, NIH, DOE, DARPA, and Taiwan NSTC. Agency-specific formatting, review criteria, budget preparation, broader impacts, significance statements, innovation narratives, and compliance with submission requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Designs statistically valid split tests for ads, audiences, landing pages, or bid strategies. Calculates required sample sizes before you start, monitors results during the test, and calls winners when statistical significance is actually reached — not when you feel like one is winning. Platform: Google and Meta.
日本語の概要は準備中です。原文の説明を表示しています。
Meta-skill for publication-ready figures. Use when creating journal submission figures requiring multi-panel layouts, significance annotations, error bars, colorblind-safe palettes, and specific journal formatting (Nature, Science, Cell). Orchestrates matplotlib/seaborn/plotly with publication styles. For quick exploration use seaborn or plotly directly.
日本語の概要は準備中です。原文の説明を表示しています。
Write competitive research proposals for NSF, NIH, DOE, DARPA, and Taiwan NSTC. Agency-specific formatting, review criteria, budget preparation, broader impacts, significance statements, innovation narratives, and compliance with submission requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Create publication figures with matplotlib/seaborn/plotly. Multi-panel layouts, error bars, significance markers, colorblind-safe, export PDF/EPS/TIFF, for journal-ready scientific plots.
日本語の概要は準備中です。原文の説明を表示しています。
Unified biological database evidence owner. Use for gene annotation, variant clinical significance, cancer mutation evidence, GWAS trait associations, pathway mapping, target-disease evidence, protein structures, protein interaction networks, reference single-cell census queries, and cross-database biological ID mapping. Do not use for full single-cell analysis, bulk RNA-seq differential expression, BAM/VCF processing, protein embedding models, metabolic flux modeling, genomic interval ML, or flow-cytometry file parsing.
日本語の概要は準備中です。原文の説明を表示しています。
Use when needing clinical significance, pathogenicity classifications (e.g., Pathogenic, Benign, VUS), clinical evidence rationales, or finding "hard positive" benchmark controls for human genomic variants.
日本語の概要は準備中です。原文の説明を表示しています。
Use when you want to look up, map, and search for short genetic variants (SNPs, indels) in NCBI's dbSNP database. Resolves between rsIDs, genomic coordinates in VCF format, and HGVS strings. For an rsID, returns variant type, gene associations, clinical significance, allele frequencies, and genomic coordinates (GRCh38).
日本語の概要は準備中です。原文の説明を表示しています。
Analyzes genetic variant effects on gene expression (RNA-seq), chromatin accessibility (DNASE), histone marks (ChIP), and transcription factors using the AlphaGenome API. Use when the user asks about non-coding variant effects, pathogenicity, clinical significance, disease associations, functional effects, gene expression changes, splicing disruption, or regulatory effects in promoters and enhancers. Also use for resolving biological terms to tissue/cell-type ontologies (UBERON/CL) or analyzing variants in chr:pos:ref>alt format.
日本語の概要は準備中です。原文の説明を表示しています。
Gene Set Enrichment Analysis using clusterProfiler gseGO and gseKEGG. Use when analyzing ranked gene lists to find coordinated expression changes in gene sets without arbitrary significance cutoffs. Detects subtle but coordinated expression changes.
日本語の概要は準備中です。原文の説明を表示しています。
Compare Hi-C contact matrices between conditions to identify differential chromatin interactions. Compute log2 fold changes, statistical significance, and visualize differential contact maps. Use when comparing Hi-C contacts between conditions.
日本語の概要は準備中です。原文の説明を表示しています。
Detects differential alternative splicing between conditions using rMATS-turbo (BAM-based) or SUPPA2 diffSplice (TPM-based). Reports events with FDR-corrected significance and delta PSI effect sizes. Use when comparing splicing patterns between treatment groups, tissues, or disease states.
日本語の概要は準備中です。原文の説明を表示しています。
Annotate CNVs with genes, pathways, and clinical significance. Use when interpreting CNV calls or identifying affected genes from copy number analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Query ClinVar for variant pathogenicity classifications, review status, and disease associations via REST API or local VCF. Use when determining clinical significance of variants for diagnostic or research purposes.
日本語の概要は準備中です。原文の説明を表示しています。
Judge whether a market FAILED to react to news favorable to a crowded speculative position — step 2 of Jason Shapiro's COT contrarian process. Consumes a cot-contrarian-detector report (or an explicit direction) plus a Claude-curated events JSON, fetches the underlying price series with a documented fallback chain, and produces a fail-closed CONFIRMED / NOT_CONFIRMED / INSUFFICIENT_EVIDENCE verdict using a statistically validated drift-significance test (not a naive failure-ratio, which false-confirms on pure noise). Generic beyond COT — reusable for PEAD and macro-crowding news-failure checks. Use when the user asks to check news-failure confirmation, whether a crowded market "shrugged off" good/bad news, or wants to run Shapiro step 2 on a CROWDED_LONG/CROWDED_SHORT market.
日本語の概要は準備中です。原文の説明を表示しています。
Use when the user asks to "generate subject line variants", "pre-score my subject lines", or "will this subject get truncated / trigger spam filters"; produces a labeled subject + preheader variant set and a per-variant heuristic pre-score card — spam-trigger flags, length/truncation across desktop + mobile, emoji-count, and the inbox preview render (from-name + subject + preheader) — before any test is run. Not for the body copy or CTA — use email-creative-builder; not for the A/B test design or significance read — use send-experiment-designer; not for the profile-weighted EQS or the S1/S2/N1/D1 vetoes — use email-quality-auditor. 邮件主题行生成/主题行预打分/截断与垃圾词检查
日本語の概要は準備中です。原文の説明を表示しています。
Write competitive research proposals for NSF, NIH, DOE, DARPA, and Taiwan NSTC. Agency-specific formatting, review criteria, budget preparation, broader impacts, significance statements, innovation narratives, and compliance with submission requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Statistical analysis and reporting for experimental datasets; use when you need to interpret experimental results, test significance (t-tests/ANOVA), or generate reproducible reports.
日本語の概要は準備中です。原文の説明を表示しています。
Analyzes forest plots for meta-analysis, generating detailed descriptions and formatting figure legends in Chinese or English. Use when the user wants to interpret a forest plot image, describe its statistical significance (heterogeneity, p-value), and format the output with s...
日本語の概要は準備中です。原文の説明を表示しています。
Simulate structured grant peer review for biomedical proposals; use when stress-testing significance, innovation, approach, feasibility, and reviewer-facing weaknesses before submission.
日本語の概要は準備中です。原文の説明を表示しています。